Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
04/08/2016 12:00
Aug 4 (Reuters) - Parnell Pharmaceuticals Holdings Ltd
Announces Financial Results For The Six PARN.O
* Month period ended june 30, 2016
* Sees fy 2016 revenue $14 million to $16 million
* Sees fy 2017 revenue about $25 million
Source text for Eikon: ID:nGNXMZFAGa
Further company coverage: PARN.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln